No significant complication was observed.Conclusion Primary spherical aberration significantly increased according to the 1-year follow-up (ANOVA P<0.001). Primary coma and trefoil reduced after 1 year (ANOVA P values were 0.02 and 0.06, respectively). No significant change occurred in the corneal biomechanical profile. Uncorrected and corrected distance visual acuity (UDVA, CDVA), subjective refraction, keratometry, central corneal thickness, corneal biomechanical profile (Ocular Response Analysis), and whole-eye wavefront aberrometry (iTrace) were evaluated preoperatively and also postoperatively, 1 month, 3 months, 6 months, and 1 year after the operation.ResultsOne month after surgery, significant improvements were observed in UDVA (ANOVA P=0.02), mean keratometry, sphere (ANOVA P <0.001), and cylinder (ANOVA P=0.04) with no significant changes afterwards. After pocket creation with femtosecond laser (Femtec 20/10 PerfectVision), MyoRing implantation was performed. Thirty-three eyes with PMD were included into the study. PurposeTo evaluate the effect of complete intrastromal corneal ring implantations on patients with pellucid marginal degeneration (PMD).DesignProspective interventional case seriesPatients and Methods Combined treatments and improved screening could eliminate the need for surgical management in most cases of PMD. Corneal collagen cross-linking is especially exciting because it halts disease progression. Combining treatments such as ICRS, CXL, toric PIOL implantation, and refractive surgery is promising, but additional studies are needed to investigate their efficacy and safety.Īlthough little is understood about the etiology, pathophysiology, epidemiology, and genetics of PMD, new treatments are improving visual outcomes and reducing complications. CXL demonstrates effectiveness without complications, although data are limited and long-term results are needed. ICRS implantation can delay penetrating keratoplasty and improve contact lens tolerance, but does not treat the underlying process. Toric PIOL implantation is effective, but ectasia progression is a concern. Crescentic lamellar keratoplasty and TILK are effective, but technically difficult and without long-term results. CLWR is effective, but lacks long-term results. FTCWR has good visual outcomes, but with significant astigmatic drift. DALK provides visual outcomes similar to penetrating keratoplasty without the risk of immune-mediated graft rejection, but its complexity and relative novelty limit its acceptance. Penetrating keratoplasty is the treatment of last resort in PMD and is effective, but with considerable complications. Reported data for each treatment is presented. This is the first review article looking at the literature specific to PMD. To review and evaluate current and future directions in the diagnosis and surgical management of pellucid marginal degeneration (PMD), including penetrating keratoplasty, full-thickness crescentic wedge resection (FTCWR), deep anterior lamellar keratoplasty (DALK), crescentic lamellar wedge resection (CLWR), crescentic lamellar keratoplasty, tuck-in lamellar keratoplasty (TILK), toric phakic intraocular lens (PIOL) implantation, intrastromal corneal ring segment implantation (ICRS), corneal collagen cross-linking (CXL), and combined therapies.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |